COST-EFFECTIVENESS OF INFECTIVE ENDOCARDITIS PROPHYLAXIS FOR MITRAL-VALVE PROLAPSE WITH OR WITHOUT A MITRAL REGURGITANT MURMUR

被引:66
作者
DEVEREUX, RB [1 ]
FRARY, CJ [1 ]
KRAMERFOX, R [1 ]
ROBERTS, RB [1 ]
RUCHLIN, HS [1 ]
机构
[1] NEW YORK HOSP,CORNELL MED CTR,DEPT PUBL HLTH,NEW YORK,NY 10021
关键词
D O I
10.1016/0002-9149(94)90853-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To assess the cost-effectiveness of prevention of infective endocarditis (IE) and to calculate cost-effectiveness of currently recommended regimens in patients with mitral valve prolapse (MVP), data on risk of death, complications, and health-care use, and cumulative incremental health-care costs due to the occurrence of IE were combined with data on the prevalence and manifestations of MVP, estimated years of life lost, and efficacy of antibiotic prophylaxis. Effectiveness and costs of standard endocarditis prophylaxis regimens were calculated per IE case prevented and years of life saved. Under the most likely scenario, oral amoxicillin prophylaxis for all MVP patients would prevent 32 cases of IE per million dental procedures at approximate costs of $119,000 per prevented case and $21,000 per year of life saved. limiting prophylaxis to patients with mitral murmurs would prevent 80 cases of IE per million procedures at costs of about $19,000 per prevented case and $3,000 per year of life saved. Erythromycin prophylaxis was slightly less expensive than amoxicillin per benefit because of lower cost and lack of drug anaphylaxis, whereas intravenous ampicillin was 7 to 30 times more costly. Sensitivity analyses suggested that erythromycin prophylaxis might be cost-saving under some scenarios, whereas intravenous ampicillin use might cause net loss of life. Thus, prevention with oral antibiotics of the cumulative morbidity and incremental health care costs due to IE in MVP patients is reasonably cost-effective for MVP patients with mitral murmurs.
引用
收藏
页码:1024 / 1029
页数:6
相关论文
共 30 条
[1]   THE CHANGING PATTERN OF INFECTIVE ENDOCARDITIS IN CHILDHOOD [J].
AWADALLAH, SM ;
KAVEY, REW ;
BYRUM, CJ ;
SMITH, FC ;
KVESELIS, DA ;
BLACKMAN, MS .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (01) :90-94
[2]   ENDOCARDITIS PROPHYLAXIS FOR PATIENTS WITH MITRAL-VALVE PROLAPSE - A QUANTITATIVE-ANALYSIS [J].
BOR, DH ;
HIMMELSTEIN, DU .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (04) :711-717
[3]   A CONTROLLED EVALUATION OF THE RISK OF BACTERIAL-ENDOCARDITIS IN PERSONS WITH MITRAL-VALVE PROLAPSE [J].
CLEMENS, JD ;
HORWITZ, RI ;
JAFFE, CC ;
FEINSTEIN, AR ;
STANTON, BF .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (13) :776-781
[4]   A QUANTITATIVE ASSESSMENT OF PRE-DENTAL ANTIBIOTIC-PROPHYLAXIS FOR PATIENTS WITH MITRAL-VALVE PROLAPSE [J].
CLEMENS, JD ;
RANSOHOFF, DF .
JOURNAL OF CHRONIC DISEASES, 1984, 37 (07) :531-544
[5]   MITRAL-VALVE PROLAPSE AND INFECTIVE ENDOCARDITIS [J].
CORRIGALL, D ;
BOLEN, J ;
HANCOCK, EW ;
POPP, RL .
AMERICAN JOURNAL OF MEDICINE, 1977, 63 (02) :215-222
[6]   PREVENTION OF BACTERIAL-ENDOCARDITIS - RECOMMENDATIONS BY THE AMERICAN-HEART-ASSOCIATION [J].
DAJANI, AS ;
BISNO, AL ;
CHUNG, KJ ;
DURACK, DT ;
FREED, M ;
GERBER, MA ;
KARCHMER, AW ;
MILLARD, HD ;
RAHIMTOOLA, S ;
SHULMAN, ST ;
WATANAKUNAKORN, C ;
TAUBERT, KA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (22) :2919-2922
[7]  
DANCHIN N, 1989, LANCET, V1, P743
[8]   COMPLICATIONS OF MITRAL-VALVE PROLAPSE - DISPROPORTIONATE OCCURRENCE IN MEN AND OLDER PATIENTS [J].
DEVEREUX, RB ;
HAWKINS, I ;
KRAMERFOX, R ;
LUTAS, EM ;
HAMMOND, IW ;
SPITZER, MC ;
HOCHREITER, C ;
ROBERTS, RB ;
BELKIN, RN ;
KLIGFIELD, P ;
BROWN, WT ;
NILES, N ;
ALDERMAN, MH ;
BORER, JS ;
LARAGH, JH .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (05) :751-758
[9]   CLINICAL AND HEALTH-CARE COST CONSEQUENCES OF INFECTIVE ENDOCARDITIS IN MITRAL-VALVE PROLAPSE [J].
FRARY, CJ ;
DEVEREUX, RB ;
KRAMERFOX, R ;
ROBERTS, RB ;
RUCHLIN, HS .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (04) :263-267
[10]   INFECTIVE ENDOCARDITIS - OLMSTED COUNTY, MINNESOTA, 1950 THROUGH 1981 [J].
GRIFFIN, MR ;
WILSON, WR ;
EDWARDS, WD ;
OFALLON, WM ;
KURLAND, LT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (09) :1199-1202